Targeting sphingosine-1-phosphate receptors in cancer. 2011

Rebecca J Watters, and Hong-Gang Wang, and Shen-Shu Sung, and Thomas P Loughran, and Xin Liu
Penn State Hershey Cancer Institute, Pennsylvania State College of Medicine, Hershey, 17033, USA.

Sphingosine 1-phosphate (S1P) is a bioactive lipid with diverse biological functions, including cell proliferation, differentiation, angiogenesis, chemotaxis, and migration. Many of the activities of S1P are mediated through five closely related G-protein-coupled receptors of the sphingosine-1-phosphate receptor family (S1PR) which play a crucial role in sphingolipid metabolism. Each of these receptors appears to be tissue specific and to have demonstrated roles in the regulation of cell proliferation and survival in various cancer types. Further analysis of the function that S1PRs serve in hematological malignancies offers a great potential for the discovery of novel and selective therapeutic agents targeting these receptors. This review focuses on the characterization of S1PRs and their roles in cancer development in various signaling pathways mediated through specific G coupled protein. In particular, pharmacological agents targeting these S1PRs will be discussed and their potential will be examined.

UI MeSH Term Description Entries
D008246 Lysophospholipids Derivatives of PHOSPHATIDIC ACIDS that lack one of its fatty acyl chains due to its hydrolytic removal. Lysophosphatidic Acids,Lysophospholipid,Acids, Lysophosphatidic
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013110 Sphingosine An amino alcohol with a long unsaturated hydrocarbon chain. Sphingosine and its derivative sphinganine are the major bases of the sphingolipids in mammals. (Dorland, 28th ed) 4-Sphingenine,4 Sphingenine
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D049349 Receptors, Lysosphingolipid A subfamily of lysophospholipid receptors with specificity for LYSOSPHINGOLIPIDS such as sphingosine-1-phosphate and sphingosine phosphorylcholine. Lysosphingolipid Receptors,Lysosphingolipid Receptor,Receptor, Lysosphingolipid

Related Publications

Rebecca J Watters, and Hong-Gang Wang, and Shen-Shu Sung, and Thomas P Loughran, and Xin Liu
September 2021, Discover. Oncology,
Rebecca J Watters, and Hong-Gang Wang, and Shen-Shu Sung, and Thomas P Loughran, and Xin Liu
November 2006, British journal of cancer,
Rebecca J Watters, and Hong-Gang Wang, and Shen-Shu Sung, and Thomas P Loughran, and Xin Liu
March 2024, International journal of molecular sciences,
Rebecca J Watters, and Hong-Gang Wang, and Shen-Shu Sung, and Thomas P Loughran, and Xin Liu
April 2001, Prostaglandins & other lipid mediators,
Rebecca J Watters, and Hong-Gang Wang, and Shen-Shu Sung, and Thomas P Loughran, and Xin Liu
January 2007, Drug discovery today. Disease mechanisms,
Rebecca J Watters, and Hong-Gang Wang, and Shen-Shu Sung, and Thomas P Loughran, and Xin Liu
June 2017, Science China. Life sciences,
Rebecca J Watters, and Hong-Gang Wang, and Shen-Shu Sung, and Thomas P Loughran, and Xin Liu
January 2016, Advances in biological regulation,
Rebecca J Watters, and Hong-Gang Wang, and Shen-Shu Sung, and Thomas P Loughran, and Xin Liu
November 2011, Anti-cancer agents in medicinal chemistry,
Rebecca J Watters, and Hong-Gang Wang, and Shen-Shu Sung, and Thomas P Loughran, and Xin Liu
March 2021, Neuromolecular medicine,
Rebecca J Watters, and Hong-Gang Wang, and Shen-Shu Sung, and Thomas P Loughran, and Xin Liu
March 2006, Cancer cell,
Copied contents to your clipboard!